A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study. [electronic resource]
Producer: 20170629Description: 1544-1552 p. digitalISSN:- 1592-8721
- Adolescent
- Adult
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Combined Modality Therapy
- Female
- Fusion Proteins, bcr-abl -- genetics
- Hematopoietic Stem Cell Transplantation
- Humans
- Imatinib Mesylate -- administration & dosage
- Male
- Middle Aged
- Neoplasm, Residual -- diagnosis
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- diagnosis
- Protein Kinase Inhibitors -- administration & dosage
- Recurrence
- Remission Induction
- Retreatment
- Survival Analysis
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.